Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PT009 (Budesonide/Formoterol) Phase IIb in Moderate to Severe COPD
NCT02196077Phase 2Completed
- Sponsor
- Pearl Therapeutics
- Start
- Aug 2014
- Primary completion
- Mar 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of budesonide, formoterol fumarate in chronic obstructive pulmonary disease (COPD), sponsored by Pearl Therapeutics. Started Aug 2014; status: completed.
02
Drugs
budesonideformoterol fumarate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02196077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02196077.